Detailed answers about LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD, including incorporation, status, business activity, and accounts information.
When was LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD founded?
LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD was officially incorporated on 27 August 2024 and is registered under company number 15919008. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD?
LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD do?
LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD's registered address?
The registered office address of LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD is 24 IMBER CLOSE, ESHER, ENGLAND, KT10 8EB. This is the official address filed with Companies House for legal and statutory correspondence.
Is LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD financially stable?
Financial accounts for LONDON CENTRE FOR ENDOCRINOLOGY & DIABETES LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.